Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on …
Tag:
Failure
-
Type 2
-
Oramed hopes the upcoming Phase 3 trial will be even more successful. Image credit: Getty Images / Karl Tapales. oramed pharmaceutical announced that it is considering restarting a Phase 3 …